跳至主要内容
临床试验/CTRI/2022/04/041556
CTRI/2022/04/041556已完成3 期

Efficacy of Svayambhuva Guggulu and Ketakyadi Taila Nasya in management of Manyastambha(Cervical Spondylosis): A Single Arm Open Labelled Clinical Trial

Institute of teaching and research in Ayurveda Jamnagar0 个研究点目标入组 25 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1Patients having clinical features of cervical spondylosis
  • 2Age group - 18-70 years
  • 3Patient eligible for Nasya
  • 4Patients willing to accept the participation in the clinical trial

排除标准

  • 1Age below 18 years and above 70 years.
  • 2Associated conditions like fibrositis, rheumatoid arthritis, ankylosing spondylitis etc.
  • 3Patients with uncontrolled DM (RBS > 200 mg/dl), HTN (160/100 mm Hg), T.B of cervical spine, nasal polyps, serious psychiatric or somatic disease.
  • 4Pregnant and lactating mothers.
  • 5Patients not suitable for Nasya.
  • 6Patients with any previous cervical fracture or cervical spine surgery.
  • 7Patients having signs of myelopathy, infection, active cancer.
  • 8Patients having Grade 4 changes as per Kellgren and Lawrence Scale.

研究者

发起方
Institute of teaching and research in Ayurveda Jamnagar

相似试验